Published in Blood Weekly, September 29th, 2005
"Single-needle hemodialysis can be the only option in some patients and requires full heparinization," according to scientists in Slovenia, who conducted a "retrospective clinical study" to "evaluate the safety and efficacy of regional citrate anticoagulation for single-needle hemodialysis."
"Citrate anticoagulation was performed during 41 single-needle hemodialysis procedures in 24 patients at risk of bleeding, using 4% trisodium citrate, 1 M CaCl2 and calcium-free dialysate," explained J. Buturovic-Ponikvar and coauthors at the University of Ljubljana. "Safety...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.